DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure and Interactions of HIV-1 gp41 CHR-NHR Reverse Hairpin Constructs Reveal Molecular Determinants of Antiviral Activity

Journal Article · · Journal of Molecular Biology
ORCiD logo [1]; ORCiD logo [2]; ORCiD logo [1];  [1]; ORCiD logo [1];  [2]; ORCiD logo [2]; ORCiD logo [2];  [2]; ORCiD logo [2]; ORCiD logo [2]; ORCiD logo [2];  [3]; ORCiD logo [4]; ORCiD logo [5]
  1. Touro University, Vallejo, CA (United States)
  2. Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
  3. University of California, San Francisco, CA (United States)
  4. Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States). Molecular Foundry
  5. Touro University, Vallejo, CA (United States); University of California, San Francisco, CA (United States)

Engineered reverse hairpin constructs containing a partial C-heptad repeat (CHR) sequence followed by a short loop and full-length N-heptad repeat (NHR) were previously shown to form trimers in solution and to be nanomolar inhibitors of HIV-1 Env mediated fusion. Their target is the in situ gp41 fusion intermediate, and they have similar potency to other previously reported NHR trimers. However, their design implies that the NHR is partially covered by CHR, which would be expected to limit potency. An exposed hydrophobic pocket in the folded structure may be sufficient to confer the observed potency, or they may exist in a partially unfolded state exposing full length NHR. Here, in this study, we examined their structure by crystallography, CD and fluorescence, establishing that the proteins are folded hairpins both in crystal form and in solution. We examined unfolding in the milieu of the fusion reaction by conducting experiments in the presence of a membrane mimetic solvent and by engineering a disulfide bond into the structure to prevent partial unfolding. We further examined the role of the hydrophobic pocket, using a hairpin-small molecule adduct that occluded the pocket, as confirmed by X-ray footprinting. The results demonstrated that the NHR region nominally covered by CHR in the engineered constructs and the hydrophobic pocket region that is exposed by design were both essential for nanomolar potency and that interaction with membrane is likely to play a role in promoting the required inhibitor structure. The design concepts can be applied to other Class 1 viral fusion proteins.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF); USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
2467431
Journal Information:
Journal of Molecular Biology, Journal Name: Journal of Molecular Biology Journal Issue: 16 Vol. 436; ISSN 0022-2836
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (73)

Internal Dynamics of the Homotrimeric HIV-1 Viral Coat Protein gp41 on Multiple Time Scales journal February 2013
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
Covalent docking using autodock: Two-point attractor and flexible side chain methods: Covalent Docking with AutoDock journal July 2015
Correcting the Circular Dichroism Spectra of Peptides for Contributions of Absorbing Side Chains journal November 1997
Complete dissociation of the HIV-1 gp41 ectodomain and membrane proximal regions upon phospholipid binding journal January 2015
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Inhibiting HIV-1 Entry journal October 1999
Core Structure of gp41 from the HIV Envelope Glycoprotein journal April 1997
Interaction of membrane proteins and lipids with solubilizing detergents journal November 2000
Thermodynamic dissection of the interface between HIV-1 gp41 heptad repeats reveals cooperative interactions and allosteric effects journal July 2020
Biophysical studies of HIV-1 glycoprotein-41 interactions with peptides and small molecules – Effect of lipids and detergents journal December 2020
Mapping out the intricate relationship of the HIV envelope protein and the membrane environment journal April 2017
Structure, interactions and membrane topology of HIV gp41 ectodomain sequences journal July 2020
Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors journal January 2019
Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins journal August 2019
Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors journal September 2020
Peptides in the treatment of AIDS journal August 2009
HIV-1 Envelope Protein gp41: An NMR Study of Dodecyl Phosphocholine Embedded gp41 Reveals a Dynamic Prefusion Intermediate Conformation journal September 2014
Development of Container Free Sample Exposure for Synchrotron X-ray Footprinting journal December 2019
Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies journal February 2018
AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings journal July 2021
Swapped-Domain Constructs of the Glycoprotein-41 Ectodomain Are Potent Inhibitors of HIV Infection journal February 2015
Hydroxyl Radical-Mediated Modification of Proteins as Probes for Structural Proteomics journal August 2007
Protein Structure and the Energetics of Protein Stability journal August 1997
Atomic structure of the ectodomain from HIV-1 gp41 journal May 1997
Structural insight into brassinosteroid perception by BRI1 journal June 2011
Global profiling of lysine reactivity and ligandability in the human proteome journal July 2017
Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions journal December 2006
Circular dichroism spectroscopy of membrane proteins journal January 2016
A targeted covalent small molecule inhibitor of HIV-1 fusion journal January 2021
Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection journal August 2005
Dissociation of the trimeric gp41 ectodomain at the lipid–water interface suggests an active role in HIV-1 Env-mediated membrane fusion journal February 2014
Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti–HIV-1 drugs journal December 2014
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region journal September 2001
Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in  Escherichia coli journal June 1997
Atomic structure of a thermostable subdomain of HIV-1 gp41 journal November 1997
Design and Properties of N CCG -gp41, a Chimeric gp41 Molecule with Nanomolar HIV Fusion Inhibitory Activity journal June 2001
Truncation, Randomization, and Selection journal August 2011
Trimeric, Coiled-coil Extension on Peptide Fusion Inhibitor of HIV-1 Influences Selection of Resistance Pathways journal January 2012
Design of a Novel Peptide Inhibitor of HIV Fusion That Disrupts the Internal Trimeric Coiled-coil of gp41 journal April 2002
Covalent Trimers of the Internal N-terminal Trimeric Coiled-coil of gp41 and Antibodies Directed against Them Are Potent Inhibitors of HIV Envelope-mediated Cell Fusion journal May 2003
Kinetic Dependence to HIV-1 Entry Inhibition journal June 2006
Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion journal October 2000
A Bioassay for HIV-1 Based on Env-CD4 Interaction journal November 1990
Resistance to enfuvirtide, the first HIV fusion inhibitor journal July 2004
Design and characterization of swapped-domain constructs of HIV-1 glycoprotein-41 as receptors for drug discovery journal March 2015
Design of a highly potent HIV-1 fusion inhibitor targeting the gp41 pocket journal January 2015
TLSMD web server for the generation of multi-group TLS models journal January 2006
Phaser crystallographic software journal July 2007
Coot model-building tools for molecular graphics journal November 2004
Optimal description of a protein structure in terms of multiple groups undergoing TLS motion journal March 2006
Towards automated crystallographic structure refinement with phenix.refine journal March 2012
The Beamline X28C of the Center for Synchrotron Biosciences: a National Resource for Biomolecular Structure and Dynamics Experiments Using Synchrotron Footprinting journal April 2007
Development of a microsecond X-ray protein footprinting facility at the Advanced Light Source journal May 2014
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix journal October 2019
Design of an engineered N‐terminal HIV‐1 gp41 trimer with enhanced stability and potency journal April 2008
Protein Design of an HIV-1 Entry Inhibitor journal January 2001
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer journal March 2016
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy journal June 2002
Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance journal August 2010
Selection with a Peptide Fusion Inhibitor Corresponding to the First Heptad Repeat of HIV-1 gp41 Identifies Two Genetic Pathways Conferring Cross-Resistance to Peptide Fusion Inhibitors Corresponding to the First and Second Heptad Repeats (HR1 and HR2) of gp41 journal October 2011
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides journal February 1998
Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 journal April 1998
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies journal July 2005
Human Immunodeficiency Virus (HIV) gp41 Escape Mutants: Cross-Resistance to Peptide Inhibitors of HIV Fusion and Altered Receptor Activation of gp120 journal April 2005
Enfuvirtide Resistance Mutations: Impact on Human Immunodeficiency Virus Envelope Function, Entry Inhibitor Sensitivity, and Virus Neutralization journal April 2005
High-Resolution Hydroxyl Radical Protein Footprinting: Biophysics Tool for Drug Discovery journal May 2018
Disulfide by Design 2.0: a web-based tool for disulfide engineering in proteins journal December 2013
Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding journal November 2009
HIV-1 gp41 as a Target for Viral Entry Inhibition journal June 2004
Amphipathic Properties of HIV-1 gp41 Fusion Inhibitors journal December 2011
Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication journal October 2019
Targeting a Conserved Lysine in the Hydrophobic Pocket of HIV-1 gp41 Improves Small Molecule Antiviral Activity journal December 2022